文章名稱引用次數

• Ac-225-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study57
• Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.048
• FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature47
• FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC47
• Metabolic activity by F-18-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC40
• Absolute number of new lesions on F-18-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab39
• First validation of myocardial flow reserve assessed by dynamic Tc-99m-sestamibi CZT-SPECT camera: head to head comparison with O-15-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study35
• Prediction of outcome using pretreatment F-18-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy34
• Third-line treatment and Lu-177-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review33
• Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline33